A. Stenzinger

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).

N. Girard, A. Stenzinger, C. Swanton, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Cancer beyond organ and tissue specificity: Next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers

P. Hufnagl, P. Hufnagl, A. Stenzinger, 2014, International journal of cancer.

Testing for deficient mismatch repair and microsatellite instability

Arndt Hartmann, J. H. Rüschoff, Tina Bocker Edmonston, 2023, Die Pathologie.